A股異動 | 廣立微跌逾4% 股東及其一致行動人擬合計減持不超0.7967%股份
廣立微(301095.SZ)現跌4.38%報63.69元,暫成交4億元,最新市值127億元。廣立微昨日晚間公吿,合計持有公司股份1577.35萬股的股東北京武嶽峯亦合高科技產業投資合夥企業及其一致行動人上海建合工業軟件合夥企業、常州武嶽峯橋矽實業投資合夥企業計劃通過集中競價的方式減持公司股份數量不超過157萬股,即不超過公司總股本的0.7967%。減持計劃將於公吿披露之日起15個交易日後的3個月內進行。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.